| Francois Phancao, MD | |
|
8900 North Kendall Dr, Miami, FL 33176-2118 | |
| (786) 596-7670 | |
| (786) 533-9711 |
| Full Name | Francois Phancao |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 8900 North Kendall Dr, Miami, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053366021 | NPI | - | NPPES |
| 13589 | Other | FL | BLUE CROSS BLUE SHIELD |
| 307014 | Other | FL | AVMED |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | ME95736 (Florida) | Secondary |
| 208M00000X | Hospitalist | ME95736 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Medical Center | Modesto, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Valley Medical Foundation | 9830094515 | 1840 |
News Archive
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
› Verified 1 days ago
| Entity Name | Hospitalist Medicine Physicians Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184663965 PECOS PAC ID: 8426062027 Enrollment ID: O20060202000956 |
News Archive
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
› Verified 1 days ago
| Entity Name | Sutter Valley Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Francois Phancao, MD Po Box 198054, Atlanta, GA 30384-8054 Ph: () - | Francois Phancao, MD 8900 North Kendall Dr, Miami, FL 33176-2118 Ph: (786) 596-7670 |
News Archive
Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.
Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.
Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.
In a recently published article in the journal Virologica Sinica, scientists have described the development and validation of a potent nanobody that targets the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus (SARS-CoV). The nanobody efficiently and specifically blocks the interaction between RBD and angiotensin-converting enzyme 2 (ACE2) and neutralizes the virus.
› Verified 1 days ago
Lorena M Cuebas-rosado, M.D Hospitalist Medicare: Medicare Enrolled Practice Location: 1201 Nw 16th St, Miami, FL 33125 Phone: 305-575-7000 | |
Alejandro Raul Mosquera, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 9555 Sw 162nd Ave, Miami, FL 33196 Phone: 786-467-2000 | |
Liana Ruiz Hofseth, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-7670 Fax: 786-533-9711 | |
Dr. Julio Manuel Romero, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-7670 | |
Maria Roman, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-7670 Fax: 786-533-9711 | |
Annabelle Cohen, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 8900 N Kendall Dr, Miami, FL 33176 Phone: 786-596-7774 Fax: 786-596-7998 | |
Juan Serralles Allongo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1400 Nw 12th Ave, Miami, FL 33136 Phone: 305-243-1960 Fax: 305-243-5546 |